Edlund, Per, Johan Ahlgren, Karsten Bjerre, Michael Andersson, Jonas Bergh, Henning Mouridsen, Stig B. Holmberg, et al. 2011. “Dose-Tailoring of FEC Adjuvant Chemotherapy Based on Leukopenia Is Feasible and Well Tolerated. Toxicity and Dose Intensity in the Scandinavian Breast Group Phase 3 Adjuvant Trial SBG 2000-1”. Acta Oncologica 50 (3):329-37. https://doi.org/10.3109/0284186X.2011.554435.